RNA Binding Proteins in Cardiovascular Disease
Monday April 23, 2018
9:30 am
-
12:00 pm
Eastern Time (ET)
Room 15A
CVP
Chair :
Michael Tranter
University of Cincinnati
Elizabeth Tarling
University of California, Los Angeles
RNA binding proteins as key post-transcriptional mediators of gene expression in multiple cardiovascular disease processes. There are over 1000 RNA binding proteins expressed in human cells, and a large percentage of these proteins have been implicated in the development of one or more diseases. This diverse class of proteins play central roles in cardiac development as well steady-state and pathophysiological processes by regulating mRNA splicing, transport, stability and translation. This symposium will focus on the role of RNA binding proteins in the regulation of cardiovascular diseases.
Speakers
Hossein Ardehali
- Northwestern University
The Role of Tristetraprolin (TTP) in Regulating Cardiac Iron Homeostasis and Metabolism
Michael Tranter
- University of Cincinnati
Cardiac-specific Deletion of the RNA Binding Protein HuR Protects Against Pathological Cardiac Hypertrophy
Muge Kuyumcu-Martinez
- University of Texas - Medical Branch
The Role of RNA Binding Protein rbfox2 in Human Heart Diseases
Prasanna Krishnamurthy
- University of Alabama-Birmingham
HuR: Novel Regulator of Cardiovascular Pathophysiology
Carlos Fernandez-Hernando
- Yale University
Post-transcriptional Regulation of Cholesterol Homeostasis as a Mediator of Atheroslcerosis
Lauren Haar
- Loyola University Chicago
The Addition of GFP to Exosomes Influences Cardioprotective Potential Through an RNA Binding Mechanism
Elizabeth Tarling
- University of California, Los Angeles
ZFP36L1 is a Post-transcriptional Regulator of Lipid Metabolism